Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced results from.
Form 8-K Horizon Therapeutics For: Apr 28 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Vetex Medical Ltd.: Vetex Medical Announces Positive One-Year Outcomes for ReVene Thrombectomy Catheter
Study Met Primary Endpoint; 100 Percent of Patients Studied Through 12 Months Experienced Improved Symptoms and Quality of Life Vetex Medical Ltd. today announced positive one-year results from a European clinical study of patients with iliofemoral vein thrombus that demonstrated that the ReVene Thrombectomy Catheter significantly improved their symptoms and quality of life, while reducing their leg swelling. Results were presented today at VENOUS 2021, the annual meeting of the American Venous Forum, by principal investigator Stephen A. Black, MD, Consultant Vascular Surgeon, Guy s and St Thomas Hospital NHS Foundation Trust and Professor of Venous Surgery, Kings College Hospital, London.